实验方案(Protocols)

7-Bromo-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one: Handling & Use Protocol

7-Bromo-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one is a brominated bicyclic heterocyclic building block featuring a fused pyridine–oxazinone scaffold that serves as a versatile synthetic intermediate in medicinal chemistry and drug discovery research.

Product Name
7-Bromo-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one
SKU
B195659
Core Scaffold
Bicyclic pyrido[3,2-b][1,4]oxazin-3(4H)-one fused ring system
Key Functional Groups
Aryl bromide (C-7), gem-dimethyl quaternary carbon (C-2), lactam carbonyl (C-3)
Primary Application
Synthetic intermediate and building block in medicinal chemistry, palladium-catalyzed cross-coupling reactions
Recommended Storage
Store in a cool, dry place away from light, sealed under inert atmosphere

Compound Overview and Chemical Properties

7-Bromo-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one (SKU: B195659) is a bicyclic heterocyclic compound comprising a pyridine ring fused to a 1,4-oxazin-3(4H)-one (morpholinone-type) ring. The compound carries three chemically significant features: (1) an aryl bromide at the 7-position of the pyridine ring, which is highly amenable to transition-metal-catalyzed cross-coupling reactions such as Suzuki–Miyaura, Buchwald–Hartwig, and Negishi couplings; (2) a gem-dimethyl substitution at the C-2 position, which confers conformational rigidity and lipophilic character; and (3) a lactam-type carbonyl at the C-3 position, providing a hydrogen-bond acceptor site relevant to target binding in drug design.

This fused pyridine–oxazinone scaffold is of significant interest in drug discovery programs targeting kinases, GPCRs, and other therapeutic proteins, where constrained bicyclic fragments are used to improve selectivity and bioavailability. The aryl bromide handle allows direct elaboration of the core via C–C and C–N bond-forming reactions.

Materials and Safety Precautions

Materials required:

  • 7-Bromo-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one (B195659)
  • Appropriate anhydrous organic solvents (e.g., DMSO, DMF, dichloromethane, THF) for dissolution
  • Inert gas supply (nitrogen or argon) for air-sensitive operations
  • Analytical balance, volumetric glassware, magnetic stirrer
  • Personal protective equipment (PPE): lab coat, chemical-resistant gloves, safety goggles

Safety precautions: As a brominated organic heterocycle, this compound should be handled with standard laboratory precautions. Avoid inhalation of dust or vapors. Work in a well-ventilated fume hood. Consult the current Safety Data Sheet (SDS) before use. Dispose of waste in accordance with local hazardous chemical regulations. This compound has not been fully toxicologically characterized; treat as potentially harmful.

Step-by-Step Protocol: Dissolution and Stock Solution Preparation

Follow these steps to prepare a stock solution of 7-Bromo-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one for use in synthetic or biological assay workflows:

  1. Equilibrate to room temperature: Remove the vial from cold storage and allow it to equilibrate to ambient temperature for at least 15 minutes before opening to prevent moisture condensation on the solid.
  2. Weigh accurately: Using an analytical balance and a tared vessel, weigh the desired amount of compound in a fume hood. Record the exact mass.
  3. Select solvent: For general synthetic applications, anhydrous DMF or DMSO are recommended as primary solvents due to their ability to dissolve polar heterocycles. For reactions requiring non-polar media, THF or dichloromethane may be used. Confirm solubility empirically if using a novel solvent system.
  4. Dissolve: Add solvent incrementally to the weighed compound with gentle swirling or stirring. Ensure complete dissolution before adjusting to final volume. Sonication at room temperature may assist dissolution if needed.
  5. Prepare stock concentration: Calculate the required volume of solvent to achieve the desired molar concentration using the molecular formula and molecular weight of the compound. Prepare stock solutions typically in the range of 10–100 mM for synthetic use or 1–10 mM for biological screening.
  6. Storage of stock solution: Aliquot stock solutions into single-use portions where possible. Store sealed vials under inert gas at −20 °C or below. Limit freeze–thaw cycles to preserve compound integrity.

Note: Confirm the molecular weight from the current product specification sheet available on the Aladdin Scientific website for accurate concentration calculations.

Applications in Synthesis and Drug Discovery

The aryl bromide functionality at C-7 makes this compound a highly useful electrophilic partner in a range of palladium- and copper-catalyzed transformations:

  • Suzuki–Miyaura coupling: Reaction with aryl or heteroaryl boronic acids/esters in the presence of a Pd catalyst and base introduces biaryl or heteroaryl substituents at C-7, enabling rapid diversification of the pyridooxazinone core.
  • Buchwald–Hartwig amination: The C–Br bond can be converted to a C–N bond using Pd catalysis with appropriate phosphine ligands and amine nucleophiles, yielding amino-substituted analogues valuable in medicinal chemistry SAR studies.
  • Negishi and Kumada couplings: Organozinc or organomagnesium reagents can be employed to introduce alkyl or aryl groups at C-7 under Pd or Ni catalysis.
  • Miyaura borylation: The aryl bromide can be converted to an aryl boronate ester using bis(pinacolato)diboron (B2pin2) under Pd catalysis, enabling the compound to be used subsequently as a coupling partner in Suzuki reactions.

The constrained bicyclic scaffold with embedded nitrogen and oxygen atoms provides favorable pharmacokinetic properties (e.g., moderate polarity, defined three-dimensional shape) relevant to CNS and kinase-targeted drug discovery programs. Researchers are encouraged to consult primary literature for specific reaction conditions optimized for pyridooxazinone substrates.

Troubleshooting and Quality Notes

Common issues and recommended actions:

  • Poor solubility: If the compound does not dissolve readily, try warming the solvent gently (40–50 °C) with stirring, or switch to a higher-polarity solvent such as DMSO. Avoid prolonged heating, which may cause degradation.
  • Discoloration of solid: The compound should appear as a solid (color consistent with supplier specification). Any unexpected darkening may indicate degradation due to moisture, heat, or light exposure. Contact Aladdin Scientific technical support if this is observed on first opening.
  • Reduced reactivity in cross-coupling: Ensure reagents are anhydrous and reactions are run under inert atmosphere. Aged or poorly stored aryl bromides may exhibit reduced reactivity due to surface oxidation or trace moisture. Use freshly prepared solutions where possible.
  • Purity verification: Before use in critical experiments, verify purity by HPLC or NMR in accordance with the certificate of analysis (CoA) provided. Report any discrepancies to Aladdin Scientific.

For technical support, batch-specific CoA, or SDS requests, contact Aladdin Scientific customer service with the product SKU (B195659) and batch number.

Frequently asked questions

What solvents are recommended for dissolving 7-Bromo-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one?

DMSO and DMF are the recommended primary solvents for this polar heterocyclic compound, offering good solubility for stock solution preparation. For synthetic reactions, anhydrous THF or dichloromethane may also be used depending on the reaction requirements. Empirical solubility testing is advised for novel solvent systems.

Which cross-coupling reactions are most suitable for the aryl bromide in this compound?

The C-7 aryl bromide is well-suited for palladium-catalyzed Suzuki–Miyaura coupling with boronic acids, Buchwald–Hartwig amination with amines, and Negishi coupling with organozinc reagents. It can also be converted to an arylboronate via Miyaura borylation for use as a Suzuki coupling partner. Standard Pd catalyst systems (e.g., Pd(PPh3)4, Pd2(dba)3 with appropriate ligands) are applicable.

How should the compound be stored to maintain stability?

Store 7-Bromo-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one in a sealed container under an inert atmosphere (nitrogen or argon) in a cool, dry, and dark location. For long-term storage, −20 °C is recommended. Avoid repeated exposure to air, moisture, and light. Allow the vial to equilibrate to room temperature before opening to prevent condensation.

What is the significance of the gem-dimethyl group at C-2 in this compound?

The gem-dimethyl substitution at C-2 (the quaternary carbon of the oxazinone ring) introduces conformational rigidity by locking the ring conformation and prevents epimerization at that center. It also increases lipophilicity, which can influence membrane permeability and protein binding in drug discovery contexts. This motif is a common medicinal chemistry strategy to improve metabolic stability.

Where can I obtain the Certificate of Analysis (CoA) and Safety Data Sheet (SDS) for SKU B195659?

The Certificate of Analysis and Safety Data Sheet for SKU B195659 are available on the Aladdin Scientific website product page. You can also request batch-specific documentation by contacting Aladdin Scientific customer service with your order number and batch number.

References

  1. Joule, J. A.; Mills, K. Heterocyclic Chemistry, 5th ed.; Wiley-Blackwell: Oxford, 2010. General reference for bicyclic heterocyclic systems including pyrido-fused oxazinones.
  2. Miyaura, N.; Suzuki, A. Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds. Chem. Rev. 1995, 95, 2457–2483. doi:10.1021/cr00039a007
  3. Hartwig, J. F. Palladium-Catalyzed Amination of Aryl Halides: Mechanism and Rational Catalyst Design. Synlett 1997, 329–340.
  4. Ishiyama, T.; Murata, M.; Miyaura, N. Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters. J. Org. Chem. 1995, 60, 7508–7510. doi:10.1021/jo00128a024

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

目录: 实验方案(Protocols)

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《7-Bromo-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one: Handling & Use Protocol》. 阿拉丁知识库,更新于 2026年10月5日。 https://www.aladdin-e.com/zh_cn/faqs/7-bromo-22-dimethyl-2h-pyrido32-b14-oxazin-34h-one-protocol-en.html
这篇文章对您有帮助吗? Yes No 有 2 人觉得有帮助